Search by Ticker
Abbvie Inc. (NYSE:ABBV)
The following stock analysis is based on 7.6 years of data (i.e. since Jan 02, 2013). All the stock history has been downloaded.
Abbvie Inc. trades on the NYSE exchange in USD dollars.
It is in the sector.
It is currently trading at $93.25 ($94.29 the previous day).It pays a 4.89% dividend.
The next reporting date is in 85 days (2020 10 30).
CNN estimates profits for the upcoming quarter will be $2.76 per share ($12.8B). The current Canada / US exchange rate is 1.32638.
Over the past 12 months, $3769121 worth of shares have been purchased and $10221464 worth of shares have been sold by insiders.
The year over year average increase is 6.4% per year assuming steady exponential growth. The actual 5 year average is 8.06. Details on the individual increase in one year intervals is provided below.
|Past Performance||Average Price||Percent Change|
|1 year||83.888182631579||-0.9||- Below Average|
|2 year||84.645607657658||-13.3||- Below Average|
|3 year||97.65230125523||50.6||+ Above Average|
|4 year||64.832868852459||8.6||+ Above Average|
|5 year||59.713320754717||-4.7||- Below Average|
The worst drop it has had in recent years is -48.5%. It has a dropping shape to the stock curve, which means the stock has to be watched closely. If the financials are good, it could be very profitable, however if not it may not recover and should be sold.
3 Diverse Large-Cap Stocks to Buy Now to Boost Your Long-Term PortfolioTue, 04 Aug 2020 23:44:11 Investors should consider adding a few large-cap names that are prepared to grow for years to come. These three stocks also pay dividends and provide exposure to three very different and vital industries...... Read Full Article
How Neurocrine Biosciences Crushed It in Q2Tue, 04 Aug 2020 10:34:00 Neurocrine Biosciences' (NASDAQ: NBIX) 30% plunge earlier this year during the coronavirus-fueled market meltdown is practically all but forgotten now. Here's what you need to know about Neurocrine's impressive Q2 update. Neurocrine reported revenue of $302.4 million in the second quarter, a 65% ...... Read Full Article
AbbVie, Amgen and Takeda start testing drugs as COVID-19 treatmentsMon, 03 Aug 2020 11:56:00 AbbVie Inc. , Amgen Inc. , and Takeda Pharmaceutical Co. Ltd. announced they started enrolling patients in a clinical trial testing three of their drugs as treatments for severely ill and hospitalized COVID-19 patients. This includes the still investigational HIV therapy cenicriviroc, ...... Read Full Article
Members Of The COVID RandD Alliance And Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID TrialMon, 03 Aug 2020 11:30:00 Today, members of the COVID RandD; Alliance AbbVie, Inc. (NYSE: ABBV), Amgen Inc. (NASDAQ: AMGN), and Takeda Pharmaceutical Co. Ltd. (NYSE: TAK) announced the first patients enrolled in the I-SPY COVID Trial (Investigation of Serial Studies to Predict Your COVID ...... Read Full Article
AbbVie Inc.and's (NYSE:ABBV) P/E Is On The MarkMon, 03 Aug 2020 11:29:34 When close to half the companies in the United States have price-to-earnings ratios (or and"P/Eand'sand") below 17x, you may...... Read Full Article
A Giant Pension Sold Apple and Intel Stock. Here Are Two Stocks It Bought.Mon, 03 Aug 2020 11:00:00 The New York State Teachers’ Retirement System trimmed investments in Apple and Intel stock in the second quarter. The pension also bought more Nvidia and AbbVie stock.... Read Full Article
The Market Continues to Undervalue AbbVieSun, 02 Aug 2020 20:31:18 The stock trades with a single-digit multiple despite strong growth rates from products outside of Humira Continue reading...... Read Full Article
2 Stocks to Supplement Your Social Security IncomeSun, 02 Aug 2020 13:07:00 According to data published by the U.S. Social Security Administration (SSA) in December 2019, the median monthly benefit paid out to retired individuals is just $1,503. The SSA estimates that approximately nine out of 10 persons aged 65 and up collect Social Security ...... Read Full Article
AbbVie (ABBV) Q2 2020 Earnings Call TranscriptSat, 01 Aug 2020 00:32:53 ABBV earnings call for the period ending June 30, 2020.... Read Full Article
AbbVie Earnings Top, Drug Giant Rebounds Bullishly, Flashes Buy SignalFri, 31 Jul 2020 20:33:13 AbbVie earnings and sales topped views. The drug giant raised full-year EPS targets including newly acquired Allergan. AbbVie stock rose into a buy area.... Read Full Article
AbbVieand's (ABBV) Q2 Earnings and Revenues Beat EstimatesFri, 31 Jul 2020 17:09:05 AbbVie (ABBV) beats on second-quarter 2020 earnings and revenues. Shares up in pre-market trading.... Read Full Article
Pharma Stock Roundup: Q2 Earnings andand JandandJ and PFEand's Coronavirus Updates in FocusFri, 31 Jul 2020 16:44:04 Pfizerand's (PFE) coronavirus vaccine candidate enters phase III. Several drugmakers announce second-quarter results.... Read Full Article
5 Key Things Youand'll Want to Know About AbbVieand's Q2 UpdateFri, 31 Jul 2020 15:54:00 AbbVie (NYSE: ABBV) announced its second-quarter results before the market opened on Friday. How did AbbVie fare in its first quarterly results with Allergan under its wing? Here are five key things you'll want to know about AbbVie's Q2 update.... Read Full Article
Letand's Not Overlook AbbVieand's Q2 BeatFri, 31 Jul 2020 14:31:00 Apple and Amazon have stolen the show. As a matter of fact, even though this name was one of my picks for the coming year in late 2019, I really have not focused on it as much since the early May ...... Read Full Article
AbbVie Beats Earnings Expectations but Stock Falls AnywayFri, 31 Jul 2020 14:26:00 The drug company beat Wall Street earnings estimates for the second quarter but issued guidance for the full year that fell below analyst expectations.... Read Full Article
Earnings andand Economic Data DelugeFri, 31 Jul 2020 14:19:02 Earnings and Economic Data Deluge... Read Full Article
AbbVie Shares Climb After Adjusted Profit Beats Analyst ViewsFri, 31 Jul 2020 13:47:00 AbbVieand's adjusted profit beat estimates. Revenue from the immunology and oncology portfolios saw gains in the second quarter.... Read Full Article
AbbVie shares rises on strong Q2, though cosmetic Botox sales tumbled 43%Fri, 31 Jul 2020 12:14:00 Shares of AbbVie Inc. were up 1.9% in premarket trading on Thursday after the drugmaker beat expectations for the quarter. The company had a loss of $739 million, or 46 cents per share, in the second quarter of 2020. It had reported a gain ...... Read Full Article
AbbVieand's Humira powers profit beat as COVID-19 weighs on Botox salesFri, 31 Jul 2020 11:54:30 The company bought Allergan for a hefty $63 billion in May, to gain control over its medical aesthetics business including lucrative wrinkle treatment Botox and reduce dependence on Humira ahead of its U.S. patent expiry in 2023. Total Botox cosmetic comparable ...... Read Full Article
A Preview Of AbbVieand's EarningsThu, 30 Jul 2020 17:06:17 On Friday, July 31, AbbVie (NYSE: ABBV) will release its latest earnings report. Benzingaand's report can help you figure out the ins and outs of the earnings release.Earnings and Revenue Analysts covering AbbVie modeled for quarterly EPS of $2.19 on revenue ...... Read Full Article